| 2025-12-12 |
详情>>
内部人交易：
Pfeiffenberger Brent股份增加52000.00股
|
| 2025-12-02 |
股东大会：
将于2026-01-22召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Second Amended and Restated Certificate of Incorporation, as amended (the “Charter”), to effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share (“Common Stock”) by a ratio of any whole number between 1-for-5 and 1-for-30, the implementation and timing of which shall be subject to the discretion of our Board of Directors (the “Board”);
2.To approve adjournment of the Special Meeting to the extent there are insufficient votes at the Special Meeting to approve the preceding proposal or to establish a quorum.
|
| 2025-12-02 |
详情>>
股本变动：
变动后总股本8740.53万股
|
| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.11美元,归母净利润959.10万美元,同比去年增长110.60%
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益0.51美元,归母净利润4401.90万美元,同比去年增长174.27%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益0.89美元,归母净利润7656.00万美元,同比去年增长372.82%
|
| 2025-04-22 |
股东大会：
将于2025-06-12召开股东大会
会议内容 ▼▲
- 1.The election of the two director nominees that are set forth in the attached 2025 Annual Meeting Proxy Statement, or the Proxy Statement, to serve as Class I directors, whose term will expire in 2028;
2.The ratification of the appointment of Ernst & Young LLP, or EY, as our independent registered public accounting firm for the 2025 fiscal year;
3.Any other matters that may properly be brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-03-20 |
复牌提示：
2025-03-19 16:00:10 停牌，复牌日期 2025-03-19 16:30:00
|
| 2025-03-19 |
详情>>
业绩披露：
2024年年报每股收益-1.61美元,归母净利润-1.27亿美元,同比去年增长7.40%
|
| 2024-11-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.18美元,归母净利润-9049.3万美元,同比去年增长6.97%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.82美元,归母净利润-5926.9万美元,同比去年增长8.19%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.45美元,归母净利润-2806.2万美元,同比去年增长10.24%
|
| 2024-04-26 |
股东大会：
将于2024-06-20召开股东大会
会议内容 ▼▲
- 1.The election of the three director nominees that are set forth in the attached 2024 Annual Meeting Proxy Statement, or the Proxy Statement, to serve as Class III directors, whose term will expire in 2027;
2.The ratification of the appointment of Ernst & Young LLP, or EY, as our independent registered public accounting firm for the 2024 fiscal year;
3.The approval of an amendment to our Second Amended and Restated Certificate of Incorporation to limit the liability of certain of our officers of the Company as permitted by recent amendments to Delaware law;
4.To approve adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve the immediately preceding proposal;
5.Any other matters that may properly be brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-03-14 |
详情>>
业绩披露：
2023年年报每股收益-2.3美元,归母净利润-1.37亿美元,同比去年增长-4.38%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.65美元,归母净利润-9727.5万美元,同比去年增长1.99%
|
| 2023-08-09 |
详情>>
业绩披露：
2023年中报每股收益-1.1美元,归母净利润-6455.5万美元,同比去年增长5.76%
|
| 2023-04-28 |
股东大会：
将于2023-06-27召开股东大会
会议内容 ▼▲
- 1.The election of the three director nominees that are set forth in the attached 2023 Annual Meeting Proxy Statement, or the Proxy Statement, to serve as Class II directors, whose term will expire in 2026;
2.The ratification of the appointment of Ernst & Young LLP, or EY, as our independent registered public accounting firm for the 2023 fiscal year;
3.Any other matters that may properly be brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-04-21 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.The election of the three director nominees that are set forth in the attached 2022 Annual Meeting Proxy Statement, or the Proxy Statement, to serve as Class I directors, whose term will expire in 2025;
2.The ratification of the appointment of Ernst & Young LLP, or EY, as our independent registered public accounting firm for the 2022 fiscal year;
3.Any other matters that may properly be brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|